American depository receipts of European stocks were 0.6% lower at 132.93 on the Bank of New York Mellon Europe ADR Index on Monday morning.
Decliners in Continental Europe were led by Credit Suisse ( CS ), a Swiss financial services company, 6.9% lower, followed by Cellectis ( CLLS ), a French genome engineering company, down by 5.4% and Trivago ( TRVG ), which operates an online hotel search platform, 3.8% lower. Nabriva Therapeutics ( NBRV ), an Austria-based clinical-stage biopharmaceutical company, was down by 3.3%.
In the UK, Akari Therapeutics ( AKTX ), a development-stage biopharmaceutical company, was 13.7% lower, followed by Motif Bio (MTFB), a clinical-stage biopharmaceutical company, down by 5.0% and Trinity Biotech (TRIB), a manufacturer of medical diagnostic products, 3.1% lower. Adaptimmune Therapeutics (ADAP), a clinical-stage biopharmaceutical company, was down by 2.3%.
Gainers in Continental Europe were led by Natuzzi (NTZ), an Italian furniture manufacturer, 3.3% higher, followed by voxelJet (VJET), a German three-dimensional printer manufacturer, up by 2.0% and Edap (EDAP), a French medical devices developer, 1.6% higher. Unilever (UN), a Dutch consumer goods company, was up by 1.1%.
And, in the UK, Midatech (MTP), an early-stage biopharmaceutical company, was 2.6% higher, followed by Amec Foster Wheeler (AMFW), a global engineering conglomerate, up by 1.3% and Unilever (UL), a Dutch consumer goods company, 1.1% higher. National Grid (NGG), an electricity and gas utility company, was up by 0.9%.
Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.